美股市場個股詳情

TPST Tempest Therapeutics

添加自選

3.470
-0.150-4.14%

收盤價 05/08 16:00 (美東)

3.442
-0.028-0.80%

盤後 17:51 (美東)

7709.39萬總市值-1816市盈率TTM

Tempest Therapeutics股票討論區

登錄發表評論

STD0313

04/26 01:09

$Tempest Therapeutics(TPST.US)$ am I the only one holding out hope for a C&H on the 4hr

STD0313

04/19 08:36

$Tempest Therapeutics (TPST.US)$ this has been the bottom 3 times before. Any move below this would definitely be a big buy in my book. But I wouldn't rush in over a few cent. If it breaks here, it would be a major break of structure and will resume its falling knife agenda. Otherwise history says this is the spot......

Chasing_Freedom

04/13 02:48

$Tempest Therapeutics(TPST.US)$ wtf was the point of the spike

itisme

04/05 23:16

$Tempest Therapeutics(TPST.US)$
I'm hoping for a ride all the way back up

Chasing_Freedom

04/05 21:41

$Tempest Therapeutics(TPST.US)$ sad where is the hype

Trytosaveabit

04/04 20:03

Update

$Tempest Therapeutics(TPST.US)$ Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications 2 MINUTES AGO, 8:00 AM EDT VIA GLOBENEWSWIRE TPST TPST-1120, a first-in-class, oral, selective PPAR⍺ antagonist, demonstrates clinical activity in PD-1 inhibitor refractory and immune compromised cancers Based on subsequent positive randomized data, Company preparing to move TPST-1120 into pivot...